
No data
No data
No data
| CAS Number | 36322-90-4 |
| Catalog Number | AG00I77J(AGN-PC-0RC2UT) |
| Chemical Name | 2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide |
| EC Number | 252-974-3 |
| IUPAC Name | 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1λ6,2-benzothiazine-3-carboxamide |
| InChI | InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20) |
| InChI Key | QYSPLQLAKJAUJT-UHFFFAOYSA-N |
| MDL Number | MFCD00057317 |
| Molecular Formula | C15H13N3O4S |
| Molecular Weight | 331.3464 |
| SMILES | O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NC=CC=C3 |
| UNII | 13T4O6VMAM |
| Synonyms | CP 16171,
CP-16171,
CP16171,
Feldene,
Piroxicam,
piroxicam,
36322-90-4,
Feldene,
Piroxicamum,
Pyroxycam,
Roxicam,
Piroftal,
BAXO,
Artroxicam,
Bruxicam,
Caliment,
Flogobene,
Geldene,
Improntal,
Larapam,
Piroflex,
Reudene,
Roxiden,
Sasulen,
Solocalm,
Erazon,
Pirkam,
Riacen,
Zunden,
piroxicam usp,
Roxam,
CP 16171,
CP-16171,
Piroxicamum [INN-Latin],
CHF 1251,
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide,
UNII-13T4O6VMAM,
NSC 666076,
Piroxicam (Feldene),
CCRIS 3719,
4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide,
C15H13N3O4S,
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide,
EINECS 252-974-3,
AK1015,
BRN 0627692,
13T4O6VMAM,
4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide,
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid,
4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
MLS000069644,
CHEBI:8249,
QYSPLQLAKJAUJT-UHFFFAOYSA-N,
MFCD00057317,
NSC666076,
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German],
4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
NCGC00015823-02,
SMR000035997,
CAS-36322-90-4,
DSSTox_CID_1170,
DSSTox_RID_75990,
DSSTox_GSID_21170,
Pipoxicam,
Rosiden,
Akten,
Felden,
Apo-Piroxicam,
Feldene Fast,
Feldene Gel,
4-Hydroxy-2-methyl-3[pyrid-2-yl-carbamoyl]-2H-1,2-benzothiazine 1,1-dioxide,
(4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e,
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide,
4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
(Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxide,
1488516-58-0,
Feldene (TN),
Piroxicam [USAN:BAN:INN:JAN],
SR-01000000199,
Roxam;Feldene,
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1?^{6},2-benzothiazine-3-carboxamide,
Piroxicam,(S),
Piroxicam(Feldene),
Prestwick_573,
Piroxicam [USAN:USP:INN:BAN:JAN],
Spectrum_001115,
Tocris-0960,
Opera_ID_442,
AC1NQX1P,
AC1NSM2R,
AC1Q3XLJ,
Prestwick0_000211,
Prestwick1_000211,
Prestwick2_000211,
Prestwick3_000211,
Spectrum2_001287,
Spectrum3_000780,
Spectrum4_000968,
Spectrum5_001445,
Lopac-P-5654,
CHEMBL527,
P 5654,
AC1L1J3Z,
BIDD:PXR0154,
Lopac0_000900,
Oprea1_714707,
SCHEMBL13462,
SCHEMBL21350,
BSPBio_000221,
BSPBio_001030,
BSPBio_002460,
KBioGR_000370,
KBioGR_001315,
KBioSS_000370,
KBioSS_001595,
MLS000038002,
MLS001148207,
MLS001304054,
MLS004774122,
DivK1c_000369,
SPECTRUM1500491,
SPBio_001293,
SPBio_002142,
Piroxicam (JP17/USP/INN),
BPBio1_000245,
GTPL7273,
Piroxicam, >=98% (TLC),
SCHEMBL3703617,
Piroxicam for system suitability,
CHEMBL1518938,
DTXSID5021170,
BCBcMAP01_000176,
BDBM85245,
CTK7I2700,
HMS501C11,
KBio1_000369,
KBio2_000370,
KBio2_001595,
KBio2_002938,
KBio2_004163,
KBio2_005506,
KBio2_006731,
KBio3_000719,
KBio3_000720,
KBio3_001680,
KS-00000JBT,
NINDS_000369,
Piroxicam 1.0 mg/ml in Methanol,
Bio1_000363,
Bio1_000852,
Bio1_001341,
Bio2_000355,
Bio2_000835,
HMS1362D11,
HMS1568L03,
HMS1792D11,
HMS1920H22,
HMS1990D11,
HMS2089B06,
HMS2092A05,
HMS2095L03,
HMS2231G03,
HMS3262D22,
HMS3267I03,
HMS3369B07,
HMS3403D11,
HMS3429L03,
HMS3655C04,
HMS3678H15,
HMS3712L03,
Pharmakon1600-01500491,
BCP02919,
HY-B0253,
NSC_4856,
Tox21_110231,
Tox21_200151,
Tox21_500900,
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1,
ANW-43611,
BBL016493,
CCG-36403,
NSC757284,
s1713,
STK177288,
ZINC12466469,
ZINC51133897,
ZINC87724780,
(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1,
AKOS000714958,
AKOS025312555,
AKOS026749939,
Tox21_110231_1,
AM84917,
CS-2233,
DB00554,
KS-5322,
LP00900,
LS-7663,
MCULE-1939282084,
NSC-666076,
NSC-757284,
(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide,
3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
IDI1_000369,
IDI1_002110,
NCGC00015823-01,
NCGC00015823-03,
NCGC00015823-04,
NCGC00015823-05,
NCGC00015823-06,
NCGC00015823-07,
NCGC00015823-08,
NCGC00015823-09,
NCGC00015823-10,
NCGC00015823-11,
NCGC00015823-12,
NCGC00015823-13,
NCGC00015823-14,
NCGC00015823-15,
NCGC00015823-17,
NCGC00015823-18,
NCGC00021244-03,
NCGC00021244-05,
NCGC00021244-06,
NCGC00021244-07,
NCGC00021244-08,
NCGC00021244-09,
NCGC00188982-01,
NCGC00257705-01,
NCGC00261585-01,
AC-24190,
BAS 04381594,
BC204217,
NCI60_022912,
SC-16825,
ST069379,
BCP0726000299,
SBI-0050875.P004,
AB0011706,
AB2000240,
AJ-111664,
CAS_36322-90-4,
CP-16,171,
Piroxicam, meets USP testing specifications,
ST2411449,
TR-014899,
EU-0100900,
FT-0080892,
FT-0630590,
P1905,
SW219862-1,
EN300-70724,
A19556,
C01608,
D00127,
J10253,
M-9898,
AB00052074-21,
AB00052074-22,
AB00052074_23,
AB00052074_24,
322P904,
SR-01000000199-3,
SR-01000000199-5,
SR-01000000199-9,
W-106626,
SR-01000000199-12,
F0001-2399,
Piroxicam, British Pharmacopoeia (BP) Reference Standard,
Z1259192069,
Piroxicam, European Pharmacopoeia (EP) Reference Standard,
Piroxicam, United States Pharmacopeia (USP) Reference Standard,
3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1,
(3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1,
Piroxicam, Pharmaceutical Secondary Standard; Certified Reference Material,
2-methyl-N-(pyridin-2-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide,
4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide,
4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l;{6},2-benzothiazine-3-carboxamide,
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide,
4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide,
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzo-thiazine-3-carboxamide1,1-dioxide,
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide,
4-Hydroxy-3-(pyridin-2-yl-carbamoyl)-2-methyl-2H-1,2-benzothiazin-1,1-dioxide,
N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide,
(E)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide,
1044566-76-8,
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4h-1,2-benzothiazin-4-one 1,1-dioxide,
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione,
3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione,
3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda,2-benzothiazine-1,1,4-trione,
3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione,
4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1,2-dihydro-1lambda,2-benzothiazine-3-carboxamide,
Piroxicam betadex,
Brexicam,
Brexidol,
Cicladol,
Brexin,
Piroxicam olamine,
Piroxicam-d3,
Brexidol (TN),
Feldoral (TN),
Proponol (TN),
Reumador (TN),
Hotemin (TN),
Mobilis (TN),
Brexin (TN),
Erazon (TN),
Exipan (TN),
Felden (TN),
Tracam (TN),
Vurdon (TN),
Veral (TN),
Pirox von ct (TN),
piroxicam beta-cyclodextrin,
Feldene, Roxam, Piroxicam,
D00IBN,
Piroxicam (JP15/USP/INN),
CP16171,
CID4856,
Piroxicam [USAN:INN:BAN:JAN],
Piroxicam-beta-cyclodextrin complex,
C15-H13-N3-O4-S,
ACN-048770,
CID5280452,
CID5312135,
CS-W-00225,
A8503,
A10736,
D010894,
Piroxicam, 98%, a non-selective COX inhibitor - 10G 10g,
942047-64-5,
|
| Complexity | 611 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 331.063g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 331.346g/mol |
| Monoisotopic Mass | 331.063g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 108A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.1 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H317-H319 |
| Packing Group | Ⅲ |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

